New implant for addiction treatment tested in healthy volunteers
NCT ID NCT07269873
First seen Dec 09, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This early-stage study tests a new implant (BICX104) that slowly releases naltrexone over 3 months. It involves 30 healthy adults to check safety and how the drug moves in the body, comparing it to a standard monthly shot (Vivitrol). Some groups also take bupropion pills. The goal is to gather data, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE AND FEMALE VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Study Site
RECRUITINGMiami, Florida, 33106, United States
Conditions
Explore the condition pages connected to this study.